Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension
Authors
Keywords
PDE 5 inhibitors, Coronary artery disease, CAD, Hypertension, Pulmonary hypertension, Heart failure, Diabetes mellitus, Raynaud’s phenomenon
Journal
CURRENT HYPERTENSION REPORTS
Volume 15, Issue 5, Pages 475-483
Publisher
Springer Nature
Online
2013-08-06
DOI
10.1007/s11906-013-0377-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of type 5-phosphodiesterase inhibition on energy metabolism and mitochondrial biogenesis in human adipose tissue ex vivo
- (2014) L. De Toni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pulmonary Arterial Hypertension: New Insights Into the Optimal Role of Current and Emerging Prostacyclin Therapies
- (2013) Aaron B. Waxman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Sildenafil Increases Digital Skin Blood Flow During All Phases of Local Cooling in Primary Raynaud's Phenomenon
- (2012) M Roustit et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Daily Use of Sildenafil Improves Endothelial Function in Men With Type 2 Diabetes
- (2012) L. Deyoung et al. JOURNAL OF ANDROLOGY
- Tadalafil for the Treatment of Pulmonary Arterial Hypertension
- (2012) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mitochondria as a Therapeutic Target in Heart Failure
- (2012) Marina Bayeva et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway
- (2011) Vinh Q. Chau et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Vardenafil in Pulmonary Arterial Hypertension
- (2011) Zhi-Cheng Jing et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure
- (2011) Ramonna G Cvelich et al. ANNALS OF PHARMACOTHERAPY
- Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
- (2011) Lewis J. Rubin et al. CHEST
- Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies
- (2011) V. Phé et al. DIABETES & METABOLISM
- Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Metabolic Syndrome: Results of a Randomized, Placebo‐Controlled Trial
- (2011) Tim Schneider et al. Journal of Sexual Medicine
- Cardiac Uses of Phosphodiesterase-5 Inhibitors
- (2011) Bryan G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury
- (2010) Melanie Madhani et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart
- (2010) Zhongbing Lu et al. CIRCULATION
- Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension
- (2010) James J. Oliver et al. HYPERTENSION
- Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial
- (2010) Padmanabha D. Shenoy et al. RHEUMATOLOGY
- Global and regional causes of death
- (2009) C. D. Mathers et al. BRITISH MEDICAL BULLETIN
- Diabetes Exacerbates the Functional Deficiency of NO/cGMP Pathway Associated with Erectile Dysfunction in Human Corpus Cavernosum and Penile Arteries
- (2009) Javier Angulo et al. Journal of Sexual Medicine
- Diagnosis and Assessment of Pulmonary Arterial Hypertension
- (2009) David B. Badesch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions
- (2009) Ajay Nehra MAYO CLINIC PROCEEDINGS
- Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
- (2008) D. Hatzichristou et al. DIABETIC MEDICINE
- Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication
- (2008) Alfonso J De LaVega et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cardiovascular Effects of Phosphodiesterase Type 5 Inhibitors
- (2008) Charalambos Vlachopoulos et al. Journal of Sexual Medicine
- Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection
- (2007) Xiaoyin Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started